Cardiology
🇺🇸 FDA Page 2FDA news and analysis for pharmaceutical BD, investment, and market access · 9 articles on this page
Global cardiology market insights for pharma BD, investors & analysts. Track pipeline, M&A, regulatory updates & competitive intelligence.
Showing 13–21 of 21 articles
ISPOR 2026: HEOR Trends in Cardiology - What to Expect
ISPOR 2026: HEOR Policy & Pharma Pricing in Focus
Clinical Trial Cost Analysis 2024: FDA Insights on Phase 1-3 Expenses
Health Canada Approves Bracco's VUEWAY (Gadopiclenol) for Lower-Dose MRI Contrast Imaging
FDA Approves Verapamil: Cardio-Med’s Extended-Release Formulation for Hypertension
FDA Approves Xylocor: Novel Therapy for Refractory Angina
FDA Approves RAPIBLYK (Landiolol) for Pediatric Supraventricular Tachycardia - AOP Health US Expands Critical Care Treatment Options
FDA Approves CardioDetect: First AI Diagnostic Tool for Arrhythmia
FDA Approves Repatha: Key Details on Amgen's Cardiovascular Drug